Detalhe da pesquisa
1.
Efficacy/effectiveness and safety of emicizumab prophylaxis of people with hemophilia A: a systematic review and meta-analysis.
Expert Rev Hematol
; 16(12): 1087-1097, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38066708
2.
Economic Evaluation of Immune Tolerance Induction in Children With Severe Hemophilia A and High-Responding Inhibitors: A Cost-Effectiveness Analysis of Prophylaxis With Emicizumab.
Value Health Reg Issues
; 34: 31-39, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36463835